Search by Drug Name or NDC

    NDC 16714-0995-01 deferasirox 360 mg/1 Details

    deferasirox 360 mg/1

    deferasirox is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northstar Rx LLC.. The primary component is DEFERASIROX.

    Product Information

    NDC 16714-0995
    Product ID 16714-995_985bacb0-2273-4e1f-b70b-0eaca6da536f
    Associated GPIs 93100025000340
    GCN Sequence Number 073797
    GCN Sequence Number Description deferasirox TABLET 360 MG ORAL
    HIC3 C8A
    HIC3 Description METALLIC POISON,AGENTS TO TREAT
    GCN 38246
    HICL Sequence Number 033337
    HICL Sequence Number Description DEFERASIROX
    Brand/Generic Generic
    Proprietary Name deferasirox
    Proprietary Name Suffix n/a
    Non-Proprietary Name deferasirox
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 360
    Active Ingredient Units mg/1
    Substance Name DEFERASIROX
    Labeler Name Northstar Rx LLC.
    Pharmaceutical Class Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA211383
    Listing Certified Through 2022-12-31

    Package

    NDC 16714-0995-01 (16714099501)

    NDC Package Code 16714-995-01
    Billing NDC 16714099501
    Package 30 TABLET, FILM COATED in 1 BOTTLE (16714-995-01)
    Marketing Start Date 2020-03-16
    NDC Exclude Flag N
    Pricing Information N/A